Search for content, post, videos

NeoDynamics received FDA clearance

NeoNavia base unit
The company has received approval for its pulse biopsy system NeoNavia from the US Food and Drug Administration, FDA. “The FDA approval for NeoNavia is a major milestone for NeoDynamics and a stamp of quality for both the product and NeoDynamics as a whole,” says Anna Eriksrud, CEO of NeoDyna
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.